Coya Therapeutics, Inc. (COYA) earnings
COYA earnings moved a median of -0.47% by the close. Quarterly and annual COYA reports and results, each read against the price at its own news timestamp. Back to the COYA overview →
19 measured COYA earnings events.
Where these COYA earnings landedvs 18 measured COYA earnings reactions
| Middle 50% of COYA earnings reactions | -5.74% to +2.79% |
|---|---|
| Median reaction (to close) | -0.47% |
| Measured reactions | 18 |
Point-in-time · zero look-ahead
Half of the 18 COYA earnings events with a measured close landed between -5.74% and +2.79%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Coya Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update | Press release | +0.46% | -2.17% | |
| Form 10-Q Coya Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.46% | -2.17% | |
| Coya Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | Press release | +0.76% | +3.90% | |
| Form 10-Q Coya Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.76% | +3.90% | |
| Coya Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update | Press release | +0.24% | +2.88% | |
| Form 10-Q Coya Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.24% | +2.88% | |
| Form 10-K Coya Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.21% | +0.90% | |
| Form 10-Q Coya Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.17% | +0.83% | |
| Form 10-Q Coya Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q Coya Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -5.88% | |
| Form 10-K/A Coya Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.01% | -1.77% | |
| Form 10-K Coya Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -7.59% | |
| Coya Therapeutics Provides a Corporate Update and Reports Unaudited Third Quarter 2024 Financial Results | Press release | -3.53% | +2.54% | |
| Form 10-Q Coya Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -3.53% | +2.54% | |
| Coya Therapeutics Provides a Corporate Update and Reports Unaudited Second Quarter 2024 Financial Results | Press release | -1.83% | -12.58% | |
| Form 10-Q Coya Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.83% | -12.58% | |
| Coya Therapeutics Provides a Corporate Update and Reports Unaudited First Quarter 2024 Financial Results | Press release | -0.48% | -5.74% | |
| Form 10-Q Coya Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.48% | -5.74% | |
| Form 10-K Coya Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | -2.06% | +3.81% |
Keep exploring
More COYA: analyst actions → · SEC filings → · COYA overview →